BioPharma Clinical Trials
Clover Initiates Phase Ⅰ Clinical Trial for RSV Vaccine Candidate
Clover Biopharmaceuticals, Ltd. a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save li...
December 13, 2023 | News
IQVIA Experts Share Perspectives on Challenges, Opportunities, and the Transformative Role of DCTs in Asia Pacific
In a dynamically evolving landscape of clinical research, the Asia Pacific (APAC) region has emerged as a key player in adopting Decentralized Clinical Tri...
December 13, 2023 | News
First Patient Dosed in U.S. Access Program for Telix's TLX250-CDx Kidney Cancer Imaging
The patient was dosed at ARA Diagnostic Imaging at Austin Radiological Association in Austin (TX, U.S.) following U.S. Food and Drug Administrati...
December 12, 2023 | News
CStone's Sugemalimab Granted NMPA Approval for Esophageal Cancer
Sugemalimab is the world's first anti-PD-L1 monoclonal antibody approved for use in combination with fluorouracil and platinum-based chemotherapy...
December 11, 2023 | News
Regor Reports Positive Results for RGT-419B in Advanced Breast Cancer After CDK4/6 Inhibitor and Endocrine Therapy
RGT-419B, a next generation CDK4 inhibitor, was safe and well tolerated in a First-in-Human Phase 1A single agent dose escalation s...
December 08, 2023 | News
Innovent Biologics and Synaffix Expand ADC Collaboration Amid Promising Phase 1 Results
The expanded deal builds on a previous agreement signed in June 2021, under which Innovent is granted to deploy Synaffix's ADC technologies on a targe...
December 07, 2023 | News
ObvioHealth and Chemist Warehouse Partner to Power Clinical Trial Efficiency in Australia
The partnership gives sponsors easier access to a wider pool of participants by driving awareness about trials to Chemist Warehouse's customers in Australi...
December 06, 2023 | News
Sirnaomics Successfully Completes Phase I Study for Anticoagulant RNAi Therapeutic STP122G
Cohort 1 is comprised of eight subjects who completed dosing and were followed over a period of 140 days. Safety data showed there were no dose-limiting to...
December 06, 2023 | News
Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics
Lycia is using its proprietary lysosomal targeting chimeras (LYTACs) platform to discover and develop first-in-class therapeutics that degrade extracellula...
December 05, 2023 | News
Insilico Medicine Launches First Human Study for ISM5411, Oral PHD Inhibitor for IBD
ISM5411 is an oral, PHD-specific inhibitor that facilitates the treatment of IBD by inducing the expression of gut barrier protective genes. ISM5411 is ...
December 05, 2023 | News
Clarivate and VeriSIM Life Strengthen Collaboration for Efficient Drug Development
Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, ...
December 05, 2023 | News
Alecensa by Roche Cuts Risk in Asian ALK-Positive Lung Cancer Patients by Over 60%.
ALINA is the first and only Phase III study to show an improvement in disease-free survival in patients from Asia with early-stage resected ALK-posit...
December 04, 2023 | News
AWS and Accenture Aid Merck in Cloud-Powered Drug Discovery and Clinical Trial Acceleration
At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced it is working with Accenture (NYSE: ACN...
November 30, 2023 | News
Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort
Cohort 3 of the theranostic SECuRE trial investigating 64Cu/67Cu-SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has enrolled a...
November 30, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
